- Arrhythmogenic right ventricular cardiomyopathy
- Family history of sudden cardiac death
- Hypertrophic cardiomyopathy (HCM)
- Inherited cardiomyopathy
- Genetic testing
Alejandro Eduardo De Feria Alsina, MD
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Penn Medicine Provider
About me
- Assistant Professor of Clinical Medicine (Cardiovascular Medicine)
My education and training
- Vanderbilt University Medical CenterMedical School
- Massachusetts General Hospital/Brigham and Women’s HospitalResidency
- University of Pennsylvania Health SystemFellowship
Spoken languages
English
English
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Amerihealth of NJ Core
- Amerihealth of NJ Enhanced
- Amerihealth of NJ HMO
- Amerihealth of NJ Local Value
- Amerihealth of NJ POS
- Amerihealth of NJ PPO
- Amerihealth of NJ Regional Preferred
- Amerihealth of NJ Secure
- Amerihealth of NJ Ultimate (PPO)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Princeton Medical Center: Has privileges to treat patients in the hospital.
Dr. De Feria Alsina is a Penn Medicine provider.
Qualifications and experience
- Cardiovascular Disease, 2021
- Internal Medicine, 2018
- American College of Cardiology, National
- American Heart Association, National
- American Medical Association, National
- Hypertrophic Cardiomyopathy Association, National
- Cardiac arrhythmia care
All conditions and treatments
Research
Publications
Weiner SD, Liang LW, Masri A, Abraham TP, Barriales-Villa R, Cooper RM, Elliott PM, de Feria A, Maron MS, Oreziak A, Saberi S, Solomon SD, Spertus JA, Tower-Rader A, Butzner M, Godown J, Heitner SB, Jacoby DL, Kupfer S, Liu X, Malik FI, Melloni C, Simkins TJ, Wei J, Nassif ME, Owens AT. Long-Term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM. , European Journal of Heart Failure, 28(4): 2026,819-830
Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, DE Feria A, Hornsby N, Marzolf A, Owens AT. Association Between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten , Journal of Cardiac Failure, 32(7): 2026,1277-1280
Montague J, Reza N, Boakye E, Duqueney E, Austin MA, Patel P, Mahmud N, de Feria Alsina AE, Hornsby N, Marzolf AB, Owens AT. Long-Term Management of Standard-of-Care Therapy in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , J Am Coll Cardiol., 87(13 Suppl): 2026,A625
Duqueney E, Reza N, Boakye E, Montague J, Austin MA, Patel P, Mahmud N, de Feria Alsina AE, Hornsby N, Marzolf AB, Owens AT. 132-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , J Am Coll Cardiol., 87(13 Suppl): 2026,A623–A624
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, DE Feria A, Marzolf A, Owens AT. Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy , Journal of Cardiac Failure Intersections, 2(2): 2026,176-178
Shad R, Zakka C, Kaur D, Mathur M, Fong R, Cho J, Filice RW, Mongan J, Kallianos K, Khandwala N, Eng D, Leipzig M, Witschey WR, de Feria A, Ferrari VA, Ashley EA, Acker MA, Langlotz C, Hiesinger W. A Generalizable Deep Learning System for Cardiac MRI , Nature Biomedical Engineering: 2026
Reza N, Dubey A, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Marzolf A, Hornsby N, de Feria A, Carattini T, Schuler P, Owens AT. Long-Term Real-World Outcomes of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy up to 108 Weeks , Journal of Clinical Medicine, 14(22): 2025,8181
Reza N, Mahmud N, Austin MA, Duqueney E, Patel P, Boakye E, Hornsby N, de Feria A, Marzolf A, Owens AT. Hypertension in Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten , JACC Heart Failure, 13(11): 2025,102666
Reza N, Austin MA, Patel P, Duqueney E, Boakye E, Jamil H, de Feria Alsina AE, Hornsby N, Marzolf AB, Owens AT. Real World Experience and 60-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten in the US , J Am Coll Cardiol., 85(12 Suppl): 2025,1464
Thomas A Boyle, Nosheen Reza, Matthew Hyman, Gregory Supple, Vincent Y See, Amy Marzolf, Nicole Hornsby, Alejandro de Feria, Teresa Wang, Kenneth B Margulies, Anjali Tiku Owens, David S Frankel Atrial Fibrillation in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Real-World Incidence, Management, and Outcomes , Research Letter: JACC Clinical Electrophysiology, 11(2): 2025,411-413